Features of the methodology for calculating the tuberculosis screening coverage rate for children in a megalopolis
Open Access
- 2 August 2025
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 11,p. 134-142
Abstract
Introduction. The paediatric tuberculosis screening coverage rate can vary significantly depending on its calculation and planning methodology, which will ultimately affect the formation of rates in the reporting period.Aim. To review the results of annual immunological screening and the methodology for calculating the preventive tuberculosis screening coverage rates for the metropolitan population aged 1–17 years.Materials and methods. The data from 2023 healthcare facility reports on preventive screening of children aged 1–17 years in Moscow using a skin test with purified tuberculosis allergen-standard solution and a skin test using recombinant tuberculosis allergen-standard solution were used.Results. In accordance with the 2023 population screening program for early detection of tuberculosis in Moscow, the number of children screened for tuberculosis using immunoassay tests amounted to 1,900,739 (96.4% coverage of the assigned population). According to the data of Federal Statistical Monitoring (FSN) Form No. 30, 1,921,590 children (including 718,272 children aged 1–7 years) were screened for early detection of tuberculosis in Moscow healthcare facilities in 2023 (97.5% coverage rate against the program target), and 1,916,255 children were screened in healthcare facilities with assigned population (97.2% coverage rate against the program target). The preventive pediatric tuberculosis screening made it possible to identify 45 new cases of tuberculosis among children and adolescents, 86 new cases of residual post-tuberculosis changes, and also to form a high-risk group among children with altered tuberculosis allergen sensitivity (3,772).Conclusions. The paediatric tuberculosis screening coverage rate depends on its calculation methodology; it should be planned and calculated based on the number of the assigned population to be served by healthcare facilities.Keywords
This publication has 11 references indexed in Scilit:
- ESAT-6 and CFP-10 antigens as a biotechnology molecule substrate. Applications in medicineRussian Journal of Infection and Immunity, 2022
- Evaluation of effectiveness of mass screening for tuberculosis infection in children from 1 to 7 years old in MoscowTuberculosis and Lung Diseases, 2022
- Efficiency of screening for tuberculosis infection in children and adolescents in Moscow in 2019 based on the new procedure for using the intradermal test with tuberculosis recombinant allergen (ESAT-6/CFP-10)Tuberculosis and Lung Diseases, 2021
- INNOVATIVE TECHNOLOGIES FOR DETECTING AND DIAGNOSTIC OF TUBERCULOSIS IN CHILDREN AND ADOLESCENTS: ACHIEVEMENTS AND PROBLEMSPediatria. Journal named after G.N. Speransky, 2020
- Latent tuberculosis infection in children and adolescents in RussiaInternational Journal of Infectious Diseases, 2020
- Recombinant tuberculosis allergen (Diaskintest®) in tuberculosis diagnostic in Russia (meta-analysis)International Journal of Mycobacteriology, 2020
- Screening for tuberculosis infection in children and adolescents in Russia – past, present, futureTuberculosis and Lung Diseases, 2019
- Comparative sensitivity of the test with tuberculosis recombinant allergen, containing ESAT6-CFP10 protein, and Mantoux test with 2 TU PPD-L in newly diagnosed tuberculosis children and adolescents in MoscowPLOS ONE, 2018
- Taking Costs and Diagnostic Test Accuracy into Account When Designing Prevalence Studies: An Application to Childhood Tuberculosis PrevalenceMedical Decision Making, 2017
- Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseasesEuropean Respiratory Journal, 2013